Full-Time

Collections Specialist

LUX Infusion

LUX Infusion

1-10 employees

Outpatient infusion centers for IV therapies

Compensation Overview

$26 - $28/hr

Overland Park, KS, USA

Hybrid

Hybrid role with on-site days in Overland Park, Kansas.

Category
Accounting (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to LUX Infusion

See people who can refer or advise you

Requirements
  • High school diploma or GED
  • Minimum of three (3) years of experience in collections-related activities
  • Experience providing customer service to internal and external stakeholders
  • Basic proficiency with Microsoft Office (Word, Excel, PowerPoint)
Responsibilities
  • Follow up on submitted insurance claims to ensure correct and timely payment
  • Monitor and manage assigned payer accounts to minimize delinquent balances
  • Investigate denials, underpayments, and unpaid balances, determining appropriate resolution paths
  • Work directly with payers to correct issues and secure reimbursement
  • Distinguish between claims billed correctly versus those requiring correction or rebilling
  • Maintain a strong understanding of payer contracts, reimbursement methodologies, and coverage requirements
  • Collaborate with internal billing, pharmacy, and operations teams to resolve claim issues efficiently
  • Respond professionally and promptly to customer and internal inquiries related to claim status
  • Stay current on billing regulations, coding guidelines, and payer policy updates
  • Utilize clearinghouses and billing systems to support effective collections workflows
  • Assist with data entry, reporting, and administrative tasks as needed
  • Maintain accuracy, follow-through, and professionalism in all payer interactions
Desired Qualifications
  • Five (5) or more years of collections experience
  • Prior home infusion therapy billing or collections experience

LUX Infusion provides ambulatory infusion services in Alaska, delivering IV and injectable therapies outside hospital settings in spa-like centers in Anchorage, Palmer, and Fairbanks. A clinical team of physicians, nurse practitioners, and infusion nurses collaborates with referring providers, while centers handle pre-authorizations and financial assistance, serving patients with private insurance, Medicare, and Medicaid. In 2025, LUX Infusion was acquired by BioMatrix Infusion Pharmacy, integrating its care teams into a national ambulatory infusion network to expand the Pacific Northwest and accelerate growth; the company holds NICA accreditation and the AICE-Ambulatory Infusion Center of Excellence designation. Its goal is to provide high-quality, patient-centered outpatient infusion care that reduces medical costs and offers an alternative to hospital-based treatment.

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

Anchorage, Alaska

Founded

2022

Get referred to LUX Infusion

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing infusion market driven by aging demographics and rising chronic disease creates strong investment tailwinds.
  • Migration to ambulatory settings offers cost-effective alternatives aligning perfectly with LUX's Alaska-based model.
  • NICA accreditation and AICE designation enhance LUX's credibility and competitive positioning nationwide.

What critics are saying

  • BioMatrix rebranding as LUX dilutes Alaska brand identity, risking 15–25% churn in Anchorage within 3–6 months.
  • Integration under Ted Kramm may deprioritize spa model for cost-centric protocols, dropping satisfaction 20–30% in 6–9 months.
  • Aggressive national payer contracts could cut per-visit revenue 10–15% within 4–7 months due to lower reimbursement rates.

What makes LUX Infusion unique

  • LUX Infusion offers spa-like ambulatory infusion centers with heated, massage chairs across Alaska.
  • Company targets acute and chronic patients seeking cost-effective IV and injectable therapies outside hospitals.
  • LUX provides spa amenities, patient-centered care, and manages pre-authorizations with private insurance, Medicare, Medicaid.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

LUX Infusion
May 28th, 2026
LUX Infusion promotes Dan Teich to Senior Vice President, Market Access.

LUX Infusion promotes Dan Teich to Senior Vice President, Market Access. Unified leadership role aligns trade relations and managed care to strengthen distribution, manufacturer, and payor partnerships. [Plantation, FL] - May 28, 2026 - LUX Infusion, a U.S.-based, clinician-led infusion services company, today announced the promotion of Dan Teich to Senior Vice President, Market Access. In this expanded role, Teich will lead a unified market access function that brings together the company's trade relations and managed care operations under a single, cohesive strategy designed to deepen alignment with LUX Infusion's distribution, manufacturer, and payor partners. "Dan has been an exceptional leader in shaping our trade relationships, and this promotion reflects both his contributions and our confidence in his vision," said Ted Kramm, Chief Executive Officer of LUX Infusion. "By unifying trade relations and managed care under his leadership, we are creating a more integrated approach to how we work with our partners, positioning LUX Infusion to deliver greater value across the entire specialty infusion ecosystem." As SVP, Market Access, Teich will be responsible for developing and executing a comprehensive strategy that aligns the company's market access partnerships across pharmaceutical manufacturers, specialty distributors, group purchasing organizations, and health plan payors with LUX Infusion's mission to expand patient access to high-quality, accessible infusion care. Teich brings more than 15 years of expertise in pharmacy operations, supply chain management, contract negotiation, and executive leadership across the specialty infusion, health system, and retail pharmacy sectors. Prior to joining LUX Infusion, he served as Vice President of Health Systems Manufacturer Relations at Cencora (formerly AmerisourceBergen), where he led negotiations of specialty and biosimilar GPO contracts for health systems, consistently exceeding fiscal-year performance targets. Before Cencora, Teich served as Vice President of Pharmacy Purchasing and Contracting at M Health Fairview, overseeing nearly $1 billion in annual drug spend and driving significant margin improvements through strategic contracting. As Program Manager of Home Infusion and Compounding at the same organization, he grew home infusion revenue by more than 240% over four years. He also held leadership roles at PharMerica and Walgreens. Teich holds a Doctor of Pharmacy (Pharm.D.) from North Dakota State University and has been a licensed pharmacist in Minnesota since 2007. "The convergence of trade relations and managed care under a unified market access function is a natural evolution for LUX Infusion as we scale nationally," said Teich. "I'm energized by the opportunity to work even more closely with our manufacturer, distribution, and payor partners to remove barriers and ensure patients receive the therapies they need, when and where they need them." This leadership structure reflects LUX Infusion's broader commitment to building a fully integrated infusion services platform that leverages strong partner relationships to drive superior clinical outcomes, operational efficiency, and expanded patient access as the company continues its growth toward more than 50 infusion locations nationwide. About LUX Infusion. LUX Infusion is elevating infusions into an experience. As a U.S. based, clinician-led infusion services company, it provides both home infusion and ambulatory infusion center services, bringing clarity, compassion, and expertise to every patient relationship. With faster therapy starts, dedicated patient support, and continuous data sharing with providers, LUX Infusion ensures patients feel supported, and providers and partners can trust in better adherence and outcomes. Media Contact: Tara Marchese Senior Director of Marketing, LUX Infusion Tel: 954-908-7636 Email: [email protected]